Kenneth L. Davis, MD

“The hospital of the future will increasingly be only for the sickest patients.”

Kenneth L. Davis, M.D., is the CEO and President of the Mount Sinai Health System, the largest academic medical system in New York City. Dr. Davis leads the efforts that have transformed the Mount Sinai Health System into one of the nation’s largest integrated health systems, with $8 billion in revenue, 42,000 employees, eight hospitals, and an extensive ambulatory platform. During his tenure, he helped launch what has been characterized as one of the largest financial turnarounds in academic medicine, placing the institution on a trajectory of dramatic growth of both scope and ambition, entering a new era of innovation in collaborative research, education, and clinical care.

As a neurobiologist, Dean, Professor, and Chair of Mount Sinai’s Department of Psychiatry, Dr. Davis conducted pioneering research that led the FDA to approve four of the first five drugs for the treatment of Alzheimer’s disease and to a revolutionary understanding of white matter, oligodendrocytes, and myelin in the pathophysiology of schizophrenia, opening an entirely new approach to the treatment of the neurodegenerative disease. He developed the widely used Alzheimer’s Disease Assessment Scale and made significant contributions to schizophrenia research.

Dr. Davis was also the Director of the Alzheimer’s Disease Research Center, the Schizophrenia Biological Research Center, the Silvio Conte Neuroscience Center, and the Seaver Autism Center for Research and Treatment, as well as Chief of the Department of Psychiatry at the Bronx’s Veterans Affairs (VA) Medical Center.

One of the most highly cited researchers in the field of brain diseases, Dr. Davis is an elected member of the Institute of Medicine of the National Academy of Sciences and has been recognized by the Alzheimer’s Association, the Society of Biological Psychiatry, and the American Psychiatric Association. He was also awarded the George H. W. Bush Lifetime of Leadership Award from Yale University, where he earned his bachelor’s degree before obtaining his M.D. from the Icahn School of Medicine.